Powered by

Statement on Jury Verdict in Delaware Trial Against Oxford Nanopore Technologies

Mar 19, 2020 - ICT Monitor Worldwide

(GlobeNewswire) - Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not overall favorable for Pacific Biosciences, but mixed in terms of its findings.

Although the jury sided with Pacific Biosciences in finding Oxford Nanopore Technologies Ltd. and its U.S. subsidiary Oxford Nanopore Technologies, Inc. guil...